Phase I Study of Intravenous Triapine (IND 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies.

Trial Profile

Phase I Study of Intravenous Triapine (IND 68338) in Combination With Pelvic Radiation Therapy With or Without Weekly Intravenous Cisplatin Chemotherapy for Locally Advanced Cervical, Vaginal, or Pelvic Gynecologic Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 10 Jan 2013

At a glance

  • Drugs OCX 191 (Primary) ; Cisplatin
  • Indications Cervical cancer; Endometrial cancer; Ovarian cancer; Vulvovaginal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 16 Mar 2010 Actual patient number (11) added as reported by ClinicalTrials.gov.
    • 16 Mar 2010 Actual end date (Aug 2009) added as reported by ClinicalTrials.gov.
    • 01 Sep 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top